- Biomemory's DNA-Based Solutions Address Data Storage Issues
- DNA storage is compact, durable and environmentally friendly.
- $18M Funding Supports Product Development and Industry Partnerships
Biomemory, a French startup founded in 2021, has long been working to develop DNA-based data storage technology.
It was the first company to make a DNA storage device available to the general public, marking a first step in the commercialization of this technology. The biomemory approach involves encoding digital data within synthesized DNA strands by translating DNA bases (A, C, G, and T) into binary code. The data can then be recovered by sequencing the DNA and converting it back to binary.
DNA storage is seen as a potential solution to the growing global demand for storage, driven by increasing data generation. It is estimated that by 2025 humanity will produce 175 zettabytes of data, a figure that challenges the capacity and sustainability of existing storage methods. The compact and durable nature of DNA offers an alternative that could reduce spatial and environmental footprints while providing long-term stability.
Secured financing
Several startups have entered the DNA storage space in recent years, including Catalog, Ansa Biotechnologies and Iridia in the United States, as well as Helixworks, DNA Script and BioSistemika in Europe. Biomemory focuses on creating comprehensive data center solutions, using biologically derived DNA fragments that are designed to last thousands of years without requiring energy for maintenance.
To further its efforts, Biomemory recently secured $18 million in Series A funding.
“This investment marks a pivotal moment for Biomemory and the future of data storage,” said Erfane Arwani, CEO and co-founder of the startup. “With our DNA storage technology, we are not only addressing today's data challenges: we are creating solutions that will sustain the ecosystem for the next century and beyond. By sharing this value with our partners and collaborators, we aim to collectively advance the industry and foster a thriving data storage ecosystem.”
Biomemory intends to use the funds to develop its first-generation data storage device, optimize biotechnology processes and accelerate commercialization. Additional goals include forming partnerships with industry players and cloud providers and recruiting experts in biology and molecular engineering.
The technology offers the potential to store all of humanity's data in a single data center rack and Biomemory plans to scale its molecular storage solutions to exabyte capacity by 2030, considering sustainability and durability as its key priorities.
